secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001472375-26-000113
Event type: leadership
Sentiment:  negative
Materiality: 0.70
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma suspends CFO Kenneth Perry; appoints Don E. Ray as interim CFO
-------------------------------------------------------------------------------

- CFO Kenneth Perry placed on administrative suspension leave with pay, effective March 31, 2026, due to concerns over compliance, financial oversight, governance, and internal controls.
- Don E. Ray appointed Interim CFO effective April 1, 2026, for an initial 90-day term at an annual salary of $150,000.
- Board reassigned Perry's duties to interim CFO; review of the concerns is ongoing with no final determinations yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000113/0001472375-26-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000113/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-26-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer